Towards an Understanding of Retinal Diseases and Novel Treatment.

Due to the cross-talk insulin signaling and the various pathogenic events in glaucoma, which still need to be better understood, targeting insulin signaling might be a future therapy for glaucoma [[6]]. The Special Issue, "Towards an Understanding of Retinal Diseases and Novel Treatment", provides comprehensive information on retinal diseases such as glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, retinitis pigmentosa (RP), and others. The review by Al Hussein Al Awamlh et al. discusses if insulin signaling directly contributes to the pathogenesis of glaucoma or is rather a secondary response to the disease. Especially in high-income countries, glaucoma, diabetic retinopathy, and AMD are, for example, more common reasons for vision impairment and blindness. [Extracted from the article]